StudyFinder
MultiStem Administration for Stroke Treatment and Enhanced Recovery Study
Recruiting
This study is evaluating the efficacy of MultiStem (drug) on functional outcome in participants with ischemic stroke.
18 years and over
Inclusion Criteria:
• clinical diagnosis of ischemic stroke involving cerebral cortex
• moderate to moderately severe stroke with a persistent neurologic deficit
Exclusion Criteria:
• stroke involving other areas of the brain
• stroke or head injury within the past 6 months
Biological: MultiStem, Biological: Placebo
Brain & Nervous System
Ischemic Stroke, Stroke
Justin Eklund - eklun063@umn.edu
Muhammad Affan
PHASE3
STUDY00008000
27154
See this study on ClinicalTrials.gov